Detalhe da pesquisa
1.
Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1.
Blood
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657201
2.
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.
N Engl J Med
; 387(24): 2232-2244, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507686
3.
Teclistamab in Relapsed or Refractory Multiple Myeloma.
N Engl J Med
; 387(6): 495-505, 2022 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661166
4.
Teclistamab, a B-cell maturation antigenâ×âCD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study.
Lancet
; 398(10301): 665-674, 2021 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388396
5.
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Lancet
; 398(10297): 314-324, 2021 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175021
6.
Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply.
N Engl J Med
; 387(18): 1722-1723, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322861
7.
Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.
Biol Blood Marrow Transplant
; 23(3): 452-458, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017734
8.
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.
Br J Haematol
; 179(3): 430-438, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832957
9.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Lancet
; 387(10020): 770-8, 2016 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26673811
10.
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.
Blood
; 125(1): 199-205, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25377785
11.
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.
Biol Blood Marrow Transplant
; 21(12): 2106-2114, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26187863
12.
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 21(8): 1373-83, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25977230
13.
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 21(2): 266-74, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445023
14.
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients.
Biol Blood Marrow Transplant
; 20(3): 354-60, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24315843
15.
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.
Blood
; 120(24): 4882-91, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23012326
16.
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.
J Cell Mol Med
; 17(11): 1371-84, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251854
17.
A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.
Biol Blood Marrow Transplant
; 19(5): 799-803, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23416850
18.
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.
Biol Blood Marrow Transplant
; 19(2): 208-13, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22982534
19.
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia.
Clin Transl Sci
; 16(3): 429-435, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564917
20.
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.
Clin Lymphoma Myeloma Leuk
; 23(1): 68-77, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357295